InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Puissance Life Science Opportunities Fund VI. Insider active across 1 company, notably Bellerophon Therapeutics, Inc.. Cumulatively, 3 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €5m. Activity tracked since 7 June 2021. The latest transaction was disclosed on 7 June 2023 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Puissance Life Science Opportunities Fund VI
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
134,421 股@ US$0.832.1% 占其流量Common StockSEC:0001760460-23-000006:0
560,000 股@ US$9.4696.9% 占其流量Common StockSEC:0001760460-23-000003:0
8,189 股@ US$4.000.5% 占其流量Common StockSEC:0001760460-21-000004:0
3 条申报中的 3 条
About Puissance Life Science Opportunities Fund VI
Puissance Life Science Opportunities Fund VI is a declarant linked to Bellerophon Therapeutics, Inc. The 4 total filings include, in the recent sampled filings covered from 2021-06-08 to 2023-06-07, disposals of EUR 5020583 and no purchases.
